The survival kinases Akt and Pim as potential pharmacological targets

J Clin Invest. 2005 Oct;115(10):2618-24. doi: 10.1172/JCI26273.

Abstract

The Akt and Pim kinases are cytoplasmic serine/threonine kinases that control programmed cell death by phosphorylating substrates that regulate both apoptosis and cellular metabolism. The PI3K-dependent activation of the Akt kinases and the JAK/STAT-dependent induction of the Pim kinases are examples of partially overlapping survival kinase pathways. Pharmacological manipulation of such kinases could have a major impact on the treatment of a wide variety of human diseases including cancer, inflammatory disorders, and ischemic diseases.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Cell Survival / drug effects
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Ischemia / drug therapy
  • Ischemia / metabolism*
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*
  • Phosphorylation / drug effects
  • Protein Kinase Inhibitors / metabolism
  • Protein Kinase Inhibitors / therapeutic use*
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-akt / metabolism
  • Proto-Oncogene Proteins c-pim-1 / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-pim-1 / metabolism
  • Signal Transduction / drug effects*

Substances

  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-akt
  • Proto-Oncogene Proteins c-pim-1